Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Highlights from ASH 2016: adaptive therapy and reducing toxicity
Evolving CLL treatments: creating choices and igniting discussions
Deborah Henderson et al.
Escalating doses and improving outcomes in cutaneous T-cell lymphomas
A short discussion of the unmet needs of CLL patients